Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

4 results
Display

Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities

Krajewski , Braschi-Amirfarzan M, DiPiro PJ, Jagannathan JP, Shinagare

Oncology is a rapidly evolving field with a shift toward personalized cancer treatment. The use of therapies targeted to the molecular features of individual tumors and the tumor microenvironment has...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
T-Cell Non-Hodgkin Lymphomas: Spectrum of Disease and the Role of Imaging in the Management of Common Subtypes

Park HS, McIntosh L, Braschi-Amirfarzan M, Shinagare , Krajewski

T-cell non-Hodgkin lymphomas (NHLs) are biologically diverse, uncommon malignancies characterized by a spectrum of imaging findings according to subtype. The purpose of this review is to describe the common subtypes...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Radiology Consultation in the Era of Precision Oncology: A Review of Consultation Models and Services in the Tertiary Setting

DiPiro PJ, Krajewski , Giardino A, Braschi-Amirfarzan M, Ramaiya NH

The purpose of the article is to describe the various radiology consultation models in the Era of Precision Medicine. Since the inception of our specialty, radiologists have served as consultants...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Immune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know

Braschi-Amirfarzan M, Tirumani S, Hodi FS, Nishino M

Over the past five years immune-checkpoint inhibitors have dramatically changed the therapeutic landscape of advanced solid and hematologic malignancies. The currently approved immune-checkpoint inhibitors include antibodies to cytotoxic T-lymphocyte antigen-4,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr